[Skip to content]

EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association EPDA - European Parkinsons Disease Association
EPDA - European Parkinsons Disease Association
REWRITE TOMORROW
.

Treatment and management

The first stage of treatment is correct diagnosis and giving appropriate information and reassurance. 

Correct diagnosis is critical.  For many people reassurance that their tremor is not associated with progressive neuro-degeneration and an explanation of the condition is all that is required – certainly at the beginning.

If the tremor is intrusive and interfering with quality of life, in particular work and social/pleasure activities, then medications can be considered.  There is no specific medication for ET.  The two medicines of choice are non-selective beta blockers, such as propranolol LA, or the anticonvulsant Mysoline (primidone).

Propranolol LA can be used on an ‘as required basis’ before the individual goes into a situation where the tremor may become intrusive, for example prior to giving a speech orplaying a musical instrument in public.  The medication can also be used on a regular basis.  The average reduction in tremor amplitude is up to 50% and normal exacerbations of tremor will be prevented.  However, more than 20% of people find beta blockers unacceptable due to side effects and there are some in whom it is absolutely contraindicated, e.g. those with asthma and related disorders.

Mysoline is another first line medicine.  It has to be introduced at very low dose, as one in five people are exquisitely sensitive to it and has to be built up very slowly, but in some it can be very effective.  Theoretically there is no reason why propranolol and Mysoline cannot be used together.  Use of Mysoline has been improved with the introduction of 50 mg tablets – an average tolerated dose 125 mg three times daily.  There are a number of second line medicines which can be tried, including clonazepam, mirtazapine, phenobarbitone, but they are often disappointing.  Specific localised tremors can be helped with botulinum toxin injections into the tremogenic muscles.  This has a particular place in tremor of the head and neck, for which the effects of other medication tend to be inadequate; botulinum toxin can have a dramatic effect, but needs to be repeated at regular intervals. 

As with Parkinson’s and other involuntary movements, some people who have intrusively symptomatic tremors which do not respond well to medications can, in the absence of contraindications, be treated with the insertion of deep brain stimulators into appropriate parts of the brain.  This is called deep brain stimulation (DBS).  

Previously, those with disabling tremors who did not respond to medications, could be offered destructive surgical lesions in parts of the brain, such as thalamotomy.  With the introduction of deep brain stimulation, which is generally considered preferable, such stereotactic procedures are relatively rarely carried out now.

Complementary therapies to promote relaxation and reduce of stress can be very valuable in managing ET.  Psychological inputs, including cognitive behavioural therapy, relaxation therapies, meditation, neuro-behavioural training and neuro-linguistic programming all have parts to play in the management of some individuals.  Likewise, nutritional advice may be important.  

EPDA EPDA EPDA EPDA EPDA EPDA EPDA EPDA